Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the national registry of myocardial infarction 4

By Peterson E.D.   Pollack C.V.   Roe M.T.   for the National Registry of Myocardial Infarction NRMI 4 Investigators  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 15-15

Elsevier

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Mechanical Intervention for Acute Myocardial Infarction

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 3, Iss. 3, 2005-07 ,pp. : 173-179

Bentham Science Publishers

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Antagonists in the Treatment of Acute ST Elevation MI: From Hypotheses to Unexpected Recent Observations

By Ross Allan M.  

Journal of Thrombosis and Thrombolysis, Vol. 15, Iss. 2, 2003-04 ,pp. : 85-89

Springer Publishing Company

Access to resources Recommend Favorite

Platelet glycoprotein IIb/IIIa receptor inhibition in primary angioplasty for acute myocardial infarction: The new paradigm of direct revascularization

By Albirini Abdulhay   Brener Sorin J  

International Journal of Cardiovascular Interventions, Vol. 4, Iss. 1, 2001-03 ,pp. : 7-14

Informa Healthcare

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa receptor antagonists in acute myocardial infarction and primary coronary stenting: Not always effective

By Banai Shmuel   Medina Aharon   Keren Andre  

International Journal of Cardiovascular Interventions, Vol. 3, Iss. 4, 2000-12 ,pp. : 241-243

Informa Healthcare

Access to resources Recommend Favorite